Literature DB >> 2368710

Spurious hyperchloremia and hyperbicarbonatemia in a patient receiving pyridostigmine bromide therapy for myasthenia gravis.

I Wacks1, J R Oster, G O Pérez, D H Kett.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2368710     DOI： 10.1016/s0272-6386(12)80790-6

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN： 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  2 in total

1.  Pyridostigmine in the treatment of orthostatic hypotension.

Authors:  Jean-Michel Senard
Journal:  Clin Auton Res       Date:  2005-12       Impact factor: 4.435

2.  Spurious rise in total carbon dioxide and chloride with negative anion gap after cystogram.

Authors:  L O Abdel-Wareth; D S Lirenman; A C Halstead; D McLellan; B C Carleton
Journal:  Pediatr Nephrol       Date:  1995-06       Impact factor: 3.714
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.